Timberlyne Therapeutics is a biopharmaceutical company developing novel therapies for autoimmune disorders, focusing on advancing a monoclonal antibody targeting CD38.

Cofactr provides supply chain and logistics management platforms with a focus on risk management tools for various industries.

Angitia Biopharmaceuticals is a clinical-stage biotechnology company developing novel treatments for serious musculoskeletal diseases.

DTiQ provides SaaS-based video, analytics, and optimization solutions to enhance operational efficiency and security for multi-location businesses.

Chartbeat is a media software platform that provides analytics and insights to over 1,000 organizations globally, including major media companies.

Kailera Therapeutics is a clinical-stage biopharmaceutical company developing next-generation therapies for obesity and related metabolic conditions.

PayRange provides IoT software and payment solutions for unattended retail.

Serán Bioscience specializes in advanced drug delivery and pharmaceutical manufacturing solutions, including particle engineering and finished dose capabilities.

1440 Foods is a sports and active nutrition company that produces and distributes market-leading brands such as Pure Protein, MET-Rx, and Body Fortress, focusing on innovation and expanding distribution.

EyeBio is a clinical-stage ophthalmology biotechnology company focused on developing therapies for sight-threatening eye diseases and has expanded its Series A funding to $130 million.

Gynesonics develops minimally invasive solutions for symptomatic uterine fibroids, with their flagship product being the Sonata System®.

Nocturne is a NYC-based blockchain technology company that has raised $6 million in seed funding to develop and deploy their protocol, which enables on-chain private accounts and addresses privacy and user experience challenges within the Ethereum ecosystem.

Aiolos Bio is a clinical-stage biopharmaceutical company focused on respiratory and inflammatory conditions, with a lead drug candidate, AIO-001, that is a potentially best-in-class TSLP antibody dosed every 6 months.

Virgin Voyages is an adult-only cruise line that offers sea vacations with a variety of culinary experiences, fitness facilities, and entertainment options, departing from multiple international ports.

Nimbus Therapeutics is a clinical-stage company that uses computational chemistry and structure-based drug design to develop novel therapies for immunology, cancer, and metabolic diseases.